Literature DB >> 26232534

The course of spinal tuberculosis (Pott disease): results of the multinational, multicentre Backbone-2 study.

A Batirel1, H Erdem2, G Sengoz3, F Pehlivanoglu3, E Ramosaco4, S Gülsün5, R Tekin6, B Mete7, I I Balkan7, D Y Sevgi8, E Giannitsioti9, A Fragou9, S Kaya5, B Cetin11, T Oktenoglu12, A D Celik13, B Karaca14, E S Horasan15, M Ulug16, S Senbayrak17, S Kaya5, E Arslanalp18, R Hasbun19, S Ates-Guler20, A Willke18, S Senol21, D Inan22, E Güclü23, G T Ertem24, M M Koc18, M Tasbakan25, G Ocal1, S Kocagoz26, H Kusoglu26, T Güven27, A I Baran28, B Dede29, F Y Karadag30, H Yilmaz31, G Aslan32, D A Al-Gallad33, S Cesur24, R El-Sokkary34, F Sirmatel35, U Savasci36, G Karaahmetoglu37, H Vahaboglu30.   

Abstract

We aimed to describe clinical, laboratory, diagnostic and therapeutic features of spinal tuberculosis (ST), also known as Pott disease. A total of 314 patients with ST from 35 centres in Turkey, Egypt, Albania and Greece were included. Median duration from initial symptoms to the time of diagnosis was 78 days. The most common complications presented before diagnosis were abscesses (69%), neurologic deficits (40%), spinal instability (21%) and spinal deformity (16%). Lumbar (56%), thoracic (49%) and thoracolumbar (13%) vertebrae were the most commonly involved sites of infection. Although 51% of the patients had multiple levels of vertebral involvement, 8% had noncontiguous involvement of multiple vertebral bodies. The causative agent was identified in 41% of cases. Histopathologic examination was performed in 200 patients (64%), and 74% were consistent with tuberculosis. Medical treatment alone was implemented in 103 patients (33%), while 211 patients (67%) underwent diagnostic and/or therapeutic surgical intervention. Ten percent of the patients required more than one surgical intervention. Mortality occurred in 7 patients (2%), and 77 (25%) developed sequelae. The distribution of the posttreatment sequelae were as follows: 11% kyphosis, 6% Gibbus deformity, 5% scoliosis, 5% paraparesis, 5% paraplegia and 4% loss of sensation. Older age, presence of neurologic deficit and spinal deformity were predictors of unfavourable outcome. ST results in significant morbidity as a result of its insidious course and delayed diagnosis because of diagnostic and therapeutic challenges. ST should be considered in the differential diagnosis of patients with vertebral osteomyelitis, especially in tuberculosis-endemic regions. Early establishment of definitive aetiologic diagnosis and appropriate treatment are of paramount importance to prevent development of sequelae.
Copyright © 2015 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Pott disease; spinal tuberculosis; spondylitis; spondylodiscitis; vertebral osteomyelitis

Mesh:

Substances:

Year:  2015        PMID: 26232534     DOI: 10.1016/j.cmi.2015.07.013

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  17 in total

Review 1.  Does computed tomography-guided percutaneous catheter drainage is effective for spinal tuberculous abscess: a midterm results.

Authors:  Tinnakorn Pluemvitayaporn; Thana Pongpanumaspaisan; Piyabuth Kittithamvongs; Sombat Kunakornsawat; Pochong Sirivitayaphakorn; Chaiwat Piyaskulkaew; Pritsanai Pruttikul
Journal:  Spinal Cord Ser Cases       Date:  2022-02-07

Review 2.  Skipped multifocal extensive spinal tuberculosis involving the whole spine: A case report and literature review.

Authors:  Minhao Wu; Jiajia Su; Feifei Yan; Lin Cai; Zhouming Deng
Journal:  Medicine (Baltimore)       Date:  2018-01       Impact factor: 1.889

3.  Minimally invasive surgery for paravertebral or psoas abscess with spinal tuberculosis - a long-term retrospective study of 106 cases.

Authors:  Zhifa Zhang; Yongyu Hao; Xiangyu Wang; Zhirong Zheng; Xuelin Zhao; Chunguo Wang; Xifeng Zhang; Xuesong Zhang
Journal:  BMC Musculoskelet Disord       Date:  2020-06-06       Impact factor: 2.362

4.  Presentation and Outcomes After Medical and Surgical Treatment Versus Medical Treatment Alone of Spontaneous Infectious Spondylodiscitis: A Systematic Literature Review and Meta-Analysis.

Authors:  Davis G Taylor; Avery L Buchholz; Durga R Sure; Thomas J Buell; James H Nguyen; Ching-Jen Chen; Joshua M Diamond; Perry A Washburn; James Harrop; Christopher I Shaffrey; Justin S Smith
Journal:  Global Spine J       Date:  2018-12-13

5.  Analysis of infectious spondylodiscitis: 7-years data.

Authors:  Gulay Okay; Yasemin Akkoyunlu; Sibel Bolukcu; Bulent Durdu; Ismail Necati Hakyemez; Meliha Meric Koc
Journal:  Pak J Med Sci       Date:  2018 Nov-Dec       Impact factor: 1.088

Review 6.  Could an increase in vigilance for spinal tuberculosis at primary health care level, enable earlier diagnosis at district level in a tuberculosis endemic country?

Authors:  Karen M Galloway; Romy Parker
Journal:  Afr J Prim Health Care Fam Med       Date:  2018-06-18

7.  Delayed Diagnosis of Spinal Tuberculosis in a 44-year-old Male with Acute on Chronic Low Back Pain.

Authors:  Curt Canine; Sarah Medeck; Anthony Hackett
Journal:  Clin Pract Cases Emerg Med       Date:  2019-04-02

8.  Concordance and Discordance of Orthopedicians with Revised National Tuberculosis Control Program with Reference to Musculoskeletal Tuberculosis: A Qualitative Inquiry.

Authors:  Manoj Nagar; Ankur Joshi; Saurabh Sahu; Vivek Nagar; Arun Mitra
Journal:  Indian J Orthop       Date:  2020-04-28       Impact factor: 1.251

9.  Analysis of Treatment and Prognosis of 863 Patients with Spinal Tuberculosis in Guizhou Province.

Authors:  Guangru Cao; JingCheng Rao; Yuqiang Cai; Chong Wang; Wenbo Liao; Taiyong Chen; Jianpu Qin; Hao Yuan; Peng Wang
Journal:  Biomed Res Int       Date:  2018-09-23       Impact factor: 3.411

10.  Early surgical intervention for active thoracic spinal tuberculosis patients with paraparesis and paraplegia.

Authors:  Weiwei Li; Zheng Liu; Xiao Xiao; Zhenchao Xu; Zhicheng Sun; Zhen Zhang; Xiyang Wang
Journal:  BMC Musculoskelet Disord       Date:  2021-02-21       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.